Lates News

Evogene (EVGN.US): The Q3 2025 financial report shows a revenue of $312,000, compared to the previous value of $1.796 million and an expected value of $650,000; earnings per share is -$0.31, compared to the previous value of -$1.31 and an expected value of -$0.41.